FDA Limits J&J's COVID-19 Vaccine Over Blood Clot Risk The Food and Drug Administration (FDA) on Thursday strictly limited who can receive...
With an FDA decision right around the corner, is it time to buy AVDL stock? Keep reading to learn more and what to expect going forward....
The U.S. Food and Drug Administration indirectly refuted Pfizer's recommendation that it's all right for COVID-19 patients to take another round of Paxlovid...
Curebase has raised $40 million in second-round financing that will help it run more complex interventional trials for The post Curebase bags $40m to develop...
Despite the loss of the company's COVID-19 antibody REGEN-COV earlier in 2022, Regeneron posted a positive first quarter driven primarily by sales of...
The COVID-19 mRNA vaccines put nanomedicine in the spotlight as a potential way to treat diseases like cancer and HIV. While the field isn’t there yet,...
The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by...
Markets open higher as investors eagerly await the Federal Reserve’s latest monetary policy decision The post Stock Market Today: Dow Jones, S&P...
Hot penny stocks under $1 to watch this week. The post Hot Penny Stocks To Buy For Under $1 This Week appeared first on Penny Stocks...
In March, CordenPharma was listed among the pharma giants picked by the German government as recipients of more than $3 billion to ensure that the country...
Covid-19 vaccine manufacturers, the FDA, CDC, and vaccine experts will need to come together and make a decision within the next month on who should be...
Gilead recently collected its 5th priority review voucher, this time for its megablockbuster Covid-19 drug remdesivir, which brought in $1.5 billion last...
'Deep State' Was Working Against Trump On COVID-19 Response: Dr. Paul Alexander Authored by Harry Lee and Roman Balmakov via The Epoch Times, According...
China-based Hutchmed failed to get the U.S. Food and Drug Administration's approval for the company's proposed drug for pancreatic cancer.
Gilead recently collected its 5th priority review voucher, this time for its megablockbuster Covid-19 drug remdesivir, which brought in $1.5 billion last...
Last week I invited 4 deeply experienced biopharma execs to gather for an hour to discuss what they’ve learned over the years about developing drugs....
The U.S. Food & Drug Administration declined to approve two China-tested cancer treatments on Monday, saying one of the companies - Hutchmed Ltd. -...
Moderna Inc.'s chief medical officer said on Sunday the company's vaccine for children under 6 years old will be ready for review by a Food and...
How might one gauge the contributions of selected geographical regions to cancer immunotherapy? Initially, one might assess cancer incidence and prevalence...
By Sungho Han, PhD, and Allan I. Levey, MD, PhD When science changes, it often takes a long time for nonscientists to catch up. The prevailing...
Humanized in vivo and in vitro systems are becoming more clinically relevant and facilitating better decisions earlier in drug development. The post Animal...
Stock index futures gain ground going into key economic policy updates from the central bank. The post Top Stock Market News For Today May 2, 2022...
Children ages 6 months to under 6 years may soon have access to a Covid-19 vaccine that has been submitted to the FDA for emergency use...
Check out these pharmaceutical stocks in the stock market today. The post Top Pharmaceutical Stocks To Watch In May 2022 appeared first on Stock Market...
Welcome to TDR’s review of the Top 5 Psychedelic developments for the week of April 25. Aside from presenting a synopsis of events, we provide market...
Those of you who joined the recent AMR conference or who receive John Rex’s very useful emails or who follow his website AMR Solutions will doubtless...
Gilead got a sales boost from its Covid-19 treatment for the first quarter — to the tune of $1.5 billion. The likely temporary bump came just...
Whistleblowers: CDC, FDA "Altered" Covid Guidance And Suppressed Findings Amid Political Pressure Instead of 'following the science,' the...
Moderna Asks FDA To Authorize Covid Vaccine For Children Under 6 Moderna on Thursday became the first Covid-19 vaccine manufacturer to ask...
Orders for Merck & Co’s oral antiviral for COVID-19 helped to swell the drugmaker’s first quarter revenues by The post Merck makes $3.2bn from...